Tech Company Financing Transactions
Agensys Funding Round
Agensys closed a $3 million investment round on 3/5/2003. Backers included Silicon Valley Bank.
Transaction Overview
Company Name
Announced On
3/5/2003
Transaction Type
Debt
Amount
$3,000,000
Round
Undisclosed
Investors
Silicon Valley Bank (Mark Breneman)
Proceeds Purpose
The credit facility will fund equipment purchases and the expansion of the company's on-site antibody fermentation and purification facilities.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1545 17th St.
Santa Monica, CA 90404
USA
Santa Monica, CA 90404
USA
Phone
Website
Email Address
Overview
Agensys, Inc. is developing a pipeline of therapeutic fully human monoclonal antibodies (MAbs) to treat solid tumor cancers based on its own proprietary targets.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Donald Rice
Chief Financial Officer
Paul Kanan
Chief Scientific Officer
Aya Jakobovits
VP - Bus. Development
Christopher Morl
Browse more venture capital transactions:
Prev: 2/27/2003: Gilian Technologies venture capital transaction
Next: 3/5/2003: ItemField venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC transactions on this site come from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs